Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 71,286 | 57,078 | 42,080 | 36,085 | 34,064 |
| Operating Income | -71,286 | -57,078 | -42,080 | -36,085 | -34,064 |
| Other Income | -40 | 98 | 72 | 43 | 15 |
| Pre-tax Income | -71,326 | -56,980 | -42,008 | -36,042 | -34,049 |
| Net Income Continuous | -71,326 | -56,980 | -42,008 | -36,042 | -34,049 |
| Net Income | $-71,326 | $-56,980 | $-42,008 | $-36,042 | $-34,049 |
| EPS Basic Total Ops | -1.44 | -1.14 | -0.84 | -0.76 | -0.70 |
| EPS Basic Continuous Ops | -1.44 | -1.14 | -0.84 | -0.76 | -0.69 |
| EPS Diluted Total Ops | -1.44 | -1.14 | -0.84 | -0.76 | -0.70 |
| EPS Diluted Continuous Ops | -1.44 | -1.14 | -0.84 | -0.76 | -0.69 |
| EBITDA(a) | $-70,265 | $-55,808 | $-41,177 | $-35,371 | $-33,650 |